Neurology News and Research RSS Feed - Neurology News and Research

UF research opens door to better diagnosis and treatment of Parkinson's disease

UF research opens door to better diagnosis and treatment of Parkinson's disease

University of Florida researchers have identified a biomarker that shows the progression of Parkinson's disease in the brain, opening the door to better diagnosis and treatment of the degenerative disease. [More]
TGen and Baylor partnership set to increase treatment options for cancer patients

TGen and Baylor partnership set to increase treatment options for cancer patients

The Translational Genomics Research Institute (TGen) and Baylor Research Institute (BRI) at Dallas today announce an agreement that will focus on accelerating early detection and treatments for patients with a broad range of cancers. [More]
Depression may be a risk factor for Parkinson's disease, say Umeå University researchers

Depression may be a risk factor for Parkinson's disease, say Umeå University researchers

People with depression may be more likely to develop Parkinson's disease, according to a large study by researchers at Umeå University, Sweden, published on 20 May, 2015, in the online issue of Neurology, the medical journal of the American Academy of Neurology. [More]
Researchers find that blocking MCAM molecule could slow progression of multiple sclerosis

Researchers find that blocking MCAM molecule could slow progression of multiple sclerosis

A drug that could halt the progression of multiple sclerosis may soon be developed thanks to a discovery by a team at the CHUM Research Centre and the University of Montreal. The researchers have identified a molecule called MCAM, and they have shown that blocking this molecule could delay the onset of the disease and significantly slow its progression. [More]
DNAtrix signs agreement to utilize Alcyone's MEMS platform for direct drug delivery into glioblastoma

DNAtrix signs agreement to utilize Alcyone's MEMS platform for direct drug delivery into glioblastoma

Alcyone Lifesciences, Inc., a leader in neural intervention systems for neurological conditions and targeted drug delivery, and DNAtrix Inc., a privately held biotechnology company and a leader in oncolytic virus therapy, have entered into an exclusive clinical collaboration. Under the agreement, DNAtrix will utilize Alcyone's MEMS Cannula (AMC) targeted delivery platform for the intratumoral delivery of DNX-2401, an oncolytic adenovirus and DNAtrix's lead product for the treatment of the most aggressive form of brain cancer, glioblastoma (GBM). [More]
Grass plants can bind, uptake and transport infectious prions

Grass plants can bind, uptake and transport infectious prions

Grass plants can bind, uptake and transport infectious prions, according to researchers at The University of Texas Health Science Center at Houston (UTHealth). [More]
UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB, a global biopharmaceutical company focusing on immunology and neurology treatment and research, is sponsoring several data presentations on Cimzia (certolizumab pegol) at Digestive Disease Week 2015, taking place in Washington, DC from May 16-19. [More]
APS announces recipients of prestigious achievement awards during annual scientific meeting

APS announces recipients of prestigious achievement awards during annual scientific meeting

The American Pain Society (APS), www.americanpainsociety.org, today announced the recipients of its prestigious achievement awards during the organization's annual scientific meeting. [More]
Denali launched to discover, develop effective medicines for neurodegenerative diseases

Denali launched to discover, develop effective medicines for neurodegenerative diseases

Denali Therapeutics Inc., a new biotechnology company focused on developing effective therapies for neurodegenerative diseases, announced today that it has launched with an initial investment commitment of $217 million. [More]
BrainStorm Cell Therapeutics reports financial results for Q1 2015, provides business update

BrainStorm Cell Therapeutics reports financial results for Q1 2015, provides business update

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced financial results and provided a business update for the first quarter ended March 31, 2015. [More]
MRI screening helps in accurate and rapid stroke treatment

MRI screening helps in accurate and rapid stroke treatment

Time is critical when it comes to stroke, and early treatment is associated with better outcomes. According to the Screening with MRI for Accurate and Rapid stroke Treatment (SMART) study, small changes in quality improvement procedures enabled clinicians to use MRI scans to diagnose stroke patients before giving acute treatment, within 60 minutes of hospital arrival. [More]
UAB opens third multidisciplinary clinic for transverse myelitis

UAB opens third multidisciplinary clinic for transverse myelitis

Mike Jezdimir knows firsthand how hard it is to get appropriate medical treatment for his condition, a disease of the spinal cord called transverse myelitis. He has had it for 48 years, since he was 17. TM is fairly uncommon, and many physicians rarely encounter it. Treatment options are limited. [More]
UBM Medica recognized with three national accolades by ASHPE

UBM Medica recognized with three national accolades by ASHPE

UBM Medica announced today that Physicians Practice, a leading online community for physicians and practice management professionals, has been recognized by the American Society of Healthcare Publication Editors with three national accolades. [More]
Cardiome signs commercialization agreement with AOP for ESMOCARD products

Cardiome signs commercialization agreement with AOP for ESMOCARD products

Cardiome Pharma Corp. today announced that the company has entered a commercialization agreement with AOP Orphan Pharma to sell AOP's cardiovascular products, ESMOCARD and ESMOCARD LYO (esmolol hydrochloride) in Italy, France, Spain and Belgium. [More]
Merck KGaA, Darmstadt, Germany granted FDA Fast Track designation for development of evofosfamide

Merck KGaA, Darmstadt, Germany granted FDA Fast Track designation for development of evofosfamide

Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials today announced that the U.S. Food and Drug Administration has granted Fast Track designation for the development of evofosfamide (previously known as TH-302), administered in combination with gemcitabine, for the treatment of previously untreated patients with metastatic or locally advanced unresectable pancreatic cancer. [More]
Experts to discuss impact of telemedicine on care delivery for aging Americans at d.health Summit

Experts to discuss impact of telemedicine on care delivery for aging Americans at d.health Summit

Recent technological, legal, and clinical developments are leading to dramatic changes in the ways medical care is delivered. While this shift has the power to displace many well-established healthcare players, it also presents an opportunity to form new partnerships and business alliances among industry leaders and newcomers to improve and enhance healthcare delivery. [More]
RBD persists in Parkinson’s disease patients

RBD persists in Parkinson’s disease patients

Symptoms of rapid eye movement sleep behaviour disorder (RBD) are unlikely to resolve in patients with Parkinson’s disease, show the findings of a 3-year study. [More]
Olfactory bulb changes fall short as imaging marker for PD

Olfactory bulb changes fall short as imaging marker for PD

Functional and histopathological changes in the olfactory bulb in patients with Parkinson’s disease do not equate to a volume change that is detectable on magnetic resonance imaging, say researchers. [More]
SLU professor reveals why women have higher rates of strokes than men, suggests steps to reduce risk

SLU professor reveals why women have higher rates of strokes than men, suggests steps to reduce risk

Each year, around 55,000 more women than men will have a stroke. Longer lifespans, pregnancies and hormones all contribute to the disparity, as do illnesses that tend to strike women more frequently. Crunch the numbers and the math adds up to more strokes for women, making it important for women monitor their risk. [More]
Three UCR STEM students named winners of Strauss Scholarship

Three UCR STEM students named winners of Strauss Scholarship

Undergraduates at the University of California, Riverside are on a success roll. First, two students won Goldwater Scholarships, announced last month. Now three undergraduate students have been named winners of prestigious scholarships from the Donald A. Strauss Foundation. Highly competitive, the Strauss Scholarship is a public service scholarship given to university students in California. [More]
Advertisement